Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Healthequity Inc (NASDAQ: HQY) closed at $105.61 in the last session, down -1.71% from day before closing price of $107.45. In other words, the price has decreased by -$1.71 from its previous closing price. On the day, 0.67 million shares were traded.
Ratios:
We take a closer look at HQY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.01. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $126.
On November 15, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $108.
On April 04, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $101.JMP Securities initiated its Mkt Outperform rating on April 04, 2024, with a $101 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when SELANDER ROBERT W sold 5,750 shares for $111.29 per share. The transaction valued at 639,927 led to the insider holds 78,219 shares of the business.
ROBERT SELANDER bought 5,750 shares of HQY for $639,927 on Feb 10 ’25. On Jan 07 ’25, another insider, Elimelech Rosner, who serves as the Officer of the company, bought 1,707 shares for $97.54 each.
Valuation Measures:
As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 96.34, and their Forward P/E ratio for the next fiscal year is 28.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.96 while its Price-to-Book (P/B) ratio in mrq is 4.32.
Stock Price History:
Over the past 52 weeks, HQY has reached a high of $115.59, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is 1.75%, while the 200-Day Moving Average is calculated to be 19.26%.
Shares Statistics:
A total of 86.82M shares are outstanding, with a floating share count of 84.54M. Insiders hold about 2.45% of the company’s shares, while institutions hold 104.92% stake in the company.
